CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Class B Common Stock Common Stock
Balance a the beginning at Dec. 30, 2023	$ 29,291	$ 43,228	$ 159,132	$ (176,700)	$ 268	$ 3,363
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock	(32)	(156)	124
Class B converted into common stock	0	18				(18)
Restricted stock grants issued	0	832	(1,235)			403
Stock-based compensation expense	156		156
Net income (loss)	(2,494)			(2,494)
Other comprehensive loss	(5)				(5)
Balance at the end at Mar. 30, 2024	26,916	43,922	158,177	(179,194)	263	3,748
Balance a the beginning at Dec. 30, 2023	29,291	43,228	159,132	(176,700)	268	3,363
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,891)
Other comprehensive loss	(10)
Balance at the end at Jun. 29, 2024	27,304	43,013	158,876	(178,591)	258	3,748
Balance a the beginning at Mar. 30, 2024	26,916	43,922	158,177	(179,194)	263	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock grants forfeited	0	(64)	64
Repurchases of Common Stock	(313)	(1,054)	741
Common Stock issued		113	(113)
Restricted stock grants issued	0	96	(96)
Stock-based compensation expense	103		103
Net income (loss)	603			603
Other comprehensive loss	(5)				(5)
Balance at the end at Jun. 29, 2024	27,304	43,013	158,876	(178,591)	258	3,748
Balance a the beginning at Dec. 28, 2024	16,218	41,992	159,892	(189,700)	286	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock grants forfeited	0	(4)	4
Stock-based compensation expense	101		101
Net income (loss)	(1,697)			(1,697)
Other comprehensive loss	(5)				(5)
Balance at the end at Mar. 29, 2025	14,617	41,988	159,997	(191,397)	281	3,748
Balance a the beginning at Dec. 28, 2024	16,218	41,992	159,892	(189,700)	286	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(537)
Other comprehensive loss	(10)
Balance at the end at Jun. 28, 2025	15,807	41,930	160,117	(190,237)	276	3,721
Balance a the beginning at Mar. 29, 2025	14,617	41,988	159,997	(191,397)	281	3,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of Common Stock	(26)	(181)	155
Class B converted into common stock	0	27				(27)
Restricted stock grants issued	0	96	(96)
Stock-based compensation expense	61		61
Net income (loss)	1,160			1,160
Other comprehensive loss	(5)				(5)
Balance at the end at Jun. 28, 2025	$ 15,807	$ 41,930	$ 160,117	$ (190,237)	$ 276	$ 3,721